샘플 요청 목록

 카트 문의
시장보고서
상품코드
1873337

세계의 원내감염 대책 시장

Hospital Acquired Infection Control
발행일: | 리서치사: Market Glass, Inc. (Formerly Global Industry Analysts, Inc.) | 페이지 정보: 영문 246 Pages | 배송안내 : 1-2일 (영업일 기준)

    
    
    



※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.

세계의 원내감염 대책 시장은 2030년까지 351억 달러에 달할 전망

세계의 원내감염 대책 시장은 2024년에 307억 달러로 추정되고 있으며, 2024-2030년의 분석 기간에 CAGR 2.2%로 성장하며, 2030년까지 351억 달러에 달할 것으로 예측됩니다. 이 리포트에서 분석 대상 부문의 하나인 방호 배리어는 2.0%의 CAGR을 기록하며, 분석 기간 종료시까지 111억 달러에 달할 것으로 예측됩니다. 멸균 장비 부문의 성장률은 분석 기간에 2.5%의 CAGR로 추정되고 있습니다.

미국 시장은 83억 달러로 추정되는 한편, 중국은 3.0%의 CAGR로 성장할 것으로 예측됩니다.

미국의 원내감염 관리 시장은 2024년에 83억 달러로 추정되고 있습니다. 세계 2위의 경제 규모를 자랑하는 중국은 2024-2030년의 분석 기간에 CAGR 3.0%로 추이하며, 2030년까지 65억 달러의 시장 규모에 달할 것으로 예측됩니다. 기타 주목할 만한 지역별 시장 분석으로는 일본과 캐나다를 들 수 있으며, 각각 분석 기간 중 1.9%의 CAGR로 성장할 것으로 예측됩니다. 유럽에서는 독일이 약 1.9%의 CAGR로 성장할 것으로 예측됩니다.

세계의 원내감염 대책 시장 - 주요 동향과 촉진요인의 개요

병원내 감염 대책은 보다 안전한 의료 환경의 열쇠가 될 수 있는가?

병원내 감염(HAI)은 의료 현장에서 심각한 문제인데, 왜 감염 관리가 환자 안전에 그렇게 중요한 것일까? 병원내 감염은 환자가 병원이나 기타 의료시설에서 치료를 받는 동안 새로운 감염이 발생하는 상태를 말합니다. 이러한 감염에는 폐렴, 수술 부위 감염, 혈류 감염, 요로 감염 등이 포함되며, 종종 세균, 바이러스 또는 곰팡이에 의해 발생합니다. 효과적인 감염 대책은 이러한 감염의 확산을 막고 취약한 환자를 보호하기 위해 필수적입니다.

감염 관리의 중요성은 의료 환경 내에서 위험한 병원균의 전파를 방지하는 능력에 있습니다. 엄격한 프로토콜이 없다면 병원내 감염은 입원 기간의 장기화, 의료비 증가, 심각한 경우 생명을 위협하는 상태나 사망으로 이어질 수 있습니다. 약제 내성균이 증가함에 따라 효과적인 감염 예방 대책의 필요성이 더욱 절실해지고 있습니다. 감염 관리 관행은 보다 청결한 환경 유지, 환자 치료 결과 개선, 약제 내성 병원균 확산 억제에 기여하며 현대 의료 시스템에서 필수적인 요소로 자리 잡고 있습니다.

기술은 병원내 감염 관리를 어떻게 발전시켰을까?

기술의 발전으로 병원내 감염 관리에 사용되는 툴와 방법이 크게 강화되어 감염 예방이 더욱 효과적이고 효율적으로 이루어지고 있습니다. 가장 영향력 있는 발전 중 하나는 자외선(UV) 소독 시스템의 활용입니다. UV-C 빛은 의료 현장의 표면 및 공기 살균에 사용되며, 기존의 청소로는 제거할 수 없었던 병원균을 사멸시킵니다. 이 시스템은 수술실, 중환자실(ICU), 환자실에서 널리 채택되어 병원내 감염에 대한 추가 보호 계층을 제공합니다.

자동화된 손 위생 모니터링 시스템도 감염 관리 노력을 개선한 혁신적인 기술입니다. 이러한 시스템은 의료진의 손 위생 준수 여부를 추적 및 모니터링하고 적절한 위생 프로토콜을 준수할 수 있도록 돕습니다. 손 위생은 감염 확산을 방지하는 가장 효과적인 방법 중 하나이며, 자동화된 모니터링은 실시간 데이터를 제공하므로 준수율이 떨어졌을 때 적시에 개입할 수 있습니다.

첨단 진단기술과 실시간 모니터링 툴도 병원의 감염관리 방식을 변화시켰습니다. 병원체 신속 진단 검사를 통해 감염을 조기에 파악할 수 있으며, 감염된 환자를 신속하게 치료하고 격리할 수 있습니다. 디지털 플랫폼과 AI 기반 분석은 병원내 감염 패턴을 추적하고 잠재적인 집단 감염을 예측할 수 있는 인사이트를 제공합니다. 이러한 툴은 감염 관리 팀이 고위험 영역을 식별하고, 감염 확산을 막기 위한 표적화된 대책을 수립하는 데 도움이 됩니다.

멸균 기술도 발전하여 의료기기와 기구의 안전성이 향상되고 있습니다. 과산화수소 증기나 플라즈마 멸균기 등의 저온 살균법으로 열에 약한 기기의 효과적인 소독이 가능하여 수술기구나 의료기기를 유해한 병원균으로부터 해방시켜 줍니다. 이러한 기술은 감염 위험이 높은 침습적 시술에 사용되는 장비에서 특히 중요합니다.

항균 표면의 개발은 감염 관리에 추가적인 보호 층을 추가했습니다. 구리나 은과 같은 물질로 코팅된 표면은 의료 환경에서 박테리아 및 기타 병원균의 증식과 확산을 억제하는 것으로 입증되었습니다. 이러한 항균 표면은 침대 레일, 문 손잡이, 의료기기 등 접촉 빈도가 높은 영역에 점점 더 많이 채택되어 표면 접촉으로 인한 병원내 감염(HAI)의 위험을 줄이고 있습니다.

병원내 감염 대책이 환자의 안전과 의료 효율성에 중요한 이유는 무엇인가?

병원내 감염 대책은 환자의 안전 확보, 의료비 절감, 의료 시스템 전체의 효율성 유지에 있으며, 매우 중요합니다. 병원내 감염은 특히 면역력이 저하된 환자, 만성질환자, 수술 후 회복기에 있는 환자 등 환자의 건강에 심각한 영향을 미칠 수 있습니다. 효과적인 감염 대책은 병원균의 전파를 방지하고 치료와 회복을 방해할 수 있는 생명을 위협하는 감염으로부터 취약한 환자를 보호합니다.

감염 대책은 환자의 건강을 보호하는 것 외에도 메티실린 내성 황색포도상구균(MRSA), 카르바페넴 내성 장내세균(CRE)과 같은 약제 내성균의 확산 방지에도 기여합니다. 이러한 슈퍼버그는 치료가 어렵고, 심각한 합병증, 장기 입원, 심지어 사망에까지 이를 수 있습니다. 적절한 손 위생, 개인보호구(PPE)(PPE) 사용, 엄격한 청소 절차 등의 감염 예방 조치는 의료시설 내에서 이러한 위험한 병원균의 확산을 억제하는 데 도움이 됩니다.

감염 관리는 의료 관련 감염(HAI) 발생률을 낮추어 의료 효율성을 향상시킵니다. HAI를 관리하는 데는 많은 비용과 자원이 소요됩니다. HAI에 감염된 환자는 입원 기간 연장, 잦은 통원치료, 고가의 약품 등 추가적인 의료서비스가 필요한 경우가 많습니다. 이는 의료기관의 부담을 증가시키고, 병원과 환자 모두에게 높은 비용을 초래할 수 있습니다. 감염률을 낮춤으로써 병원은 자원 배분을 최적화하고, 환자의 재입원율을 낮추며, 전반적인 의료 성과를 향상시킬 수 있습니다.

감염 관리의 또 다른 중요한 측면은 의료진이 감염성 병원체에 노출되지 않도록 보호하는 것입니다. 의료진은 혈액, 체액, 오염된 표면과 자주 접촉하므로 감염 위험에 노출되어 있습니다. 개인보호장비(PPE), 표면 소독, 예방접종 프로그램을 포함한 적절한 감염 관리 프로토콜은 의료진을 보호하고 자신과 타인을 위험에 빠뜨리지 않고 치료를 계속할 수 있도록 도와줍니다.

병원내 감염 관리 시장의 성장을 이끄는 요인은 무엇인가?

병원내 감염 관리 시장은 HAI(병원내 감염) 발생률 증가, 감염 관리 대책에 대한 인식 증가, 의료 기술의 발전 등 몇 가지 주요 요인으로 인해 괄목할 만한 성장을 보이고 있습니다. 주요 촉진요인 중 하나는 전 세계에서 HAI의 확산이 증가하고 있다는 점입니다. 의료시설이 복잡한 의료적 요구가 있는 환자를 많이 치료함에 따라 병원 환경에서의 감염 확산 위험이 증가하고 있습니다. 이로 인해 병원들은 자외선 소독 시스템부터 첨단 모니터링 툴에 이르기까지 보다 효과적인 감염 관리 대책에 투자하고 있습니다.

특히 COVID-19 팬데믹과 같은 세계 보건 이슈로 인해 감염 예방의 중요성에 대한 인식이 높아짐에 따라 감염 관리 기술의 채택이 촉진되고 있습니다. 정부, 의료기관, 규제기관은 감염관리 기준의 개선을 더욱 중시하고 있으며, 많은 국가에서 HAI 발생률 감소를 위해 더욱 엄격한 규제를 시행하고 있습니다. 병원의 안전에 대한 대중의 인식이 높아지면서 병원의 감염 예방 노력에 대한 요구가 증가하고 있습니다.

소독 및 살균 공정의 기술적 진보도 시장 성장에 기여하고 있습니다. UV-C 및 과산화수소 증기 시스템과 같은 새로운 소독 기술은 보다 쉽게 구할 수 있게 되면서 전 세계 의료시설에서 빠르게 채택되고 있습니다. 이러한 기술은 기존 청소 방법보다 더 빠르고 철저한 소독을 실현하고 병원균 전파 위험을 줄입니다. 마찬가지로 항균 표면과 첨단 개인보호장비(PPE)의 보급은 의료진과 환자가 감염으로부터 더 안전하게 보호받을 수 있도록 돕고 있습니다.

시장 성장을 이끄는 또 다른 요인은 특히 신흥 시장의 의료 인프라에 대한 투자 증가입니다. 개발도상국들이 의료 시스템을 확장함에 따라 국제적인 의료 기준을 충족시키기 위한 감염 관리 제품 및 서비스에 대한 수요가 증가하고 있습니다. 이들 지역의 많은 의료시설은 환자 안전 향상과 병원내 감염(HAI) 확산 방지를 위해 시설과 프로토콜을 업데이트하고 있습니다.

마지막으로 환자 안전과 양질의 의료에 대한 관심이 높아짐에 따라 보다 높은 수준의 감염 관리 대책 도입이 촉진되고 있습니다. 병원은 환자를 유치하고 명성을 유지하기 위해 인증 기준을 충족하고 낮은 감염률을 보여야 한다는 압박이 점점 더 강해지고 있습니다. 실시간 모니터링, 첨단 진단 기술, 자동 소독 시스템을 포함한 감염 관리 시스템은 이러한 목표를 달성하는 데 필수적인 툴이 되고 있습니다.

감염 예방 기술에 대한 수요 증가, 의료 인프라의 발전, 병원내 감염의 위험성에 대한 인식이 높아짐에 따라 병원내 감염 관리 시장은 빠르게 확대될 것으로 예측됩니다. 의료기관이 환자의 안전과 효율성을 우선시하는 가운데, 감염관리 대책은 병원내 감염을 예방하고 환자와 의료진 모두에게 보다 건강한 치료 결과를 보장하는 데 있으며, 핵심적인 역할을 할 것입니다.

부문 :

제품별(방호 배리어, 멸균 장비, 소독제, 기타 제품), 용도별(병원·집중치료실, 외래 수술·진단 센터, 요양시설·산과 센터, 기타 용도)

조사 대상 기업의 예

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB(Getinge Group)
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

AI 통합

검증된 전문가 컨텐츠와 AI 툴을 통해 시장 및 경쟁 정보 분석을 혁신하고 있습니다.

Global Industry Analysts는 일반적인 LLM이나 산업별 SLM에 대한 쿼리 방식에 의존하는 대신, 전 세계 도메인 전문가들이 엄선한 컨텐츠 리포지토리를 구축했습니다. 여기에는 비디오 전사, 블로그, 검색엔진 조사, 그리고 방대한 양의 기업, 제품/서비스, 시장 데이터가 포함됩니다.

관세 영향 계수

이번 보고서에는 Global Industry Analysts가 예측한 본사 소재지, 생산기지, 수출입(완제품 및 OEM)에 따른 기업의 경쟁력 변화에 따라 지역 시장에 미치는 관세의 영향을 반영했습니다. 이러한 복잡하고 다면적인 시장 현실은 수입원가(COGS) 증가, 수익성 감소, 공급망 재편 등 미시적 및 거시적 시장 역학을 통해 경쟁사들에게 영향을 미칠 것입니다.

목차

제1장 조사 방법

제2장 개요

  • 시장 개요
  • 주요 기업
  • 시장 동향과 촉진요인
  • 세계 시장 전망

제3장 시장 분석

  • 미국
  • 캐나다
  • 일본
  • 중국
  • 유럽
  • 프랑스
  • 독일
  • 이탈리아
  • 영국
  • 스페인
  • 러시아
  • 기타 유럽
  • 아시아태평양
  • 호주
  • 인도
  • 한국
  • 기타 아시아태평양
  • 라틴아메리카
  • 아르헨티나
  • 브라질
  • 멕시코
  • 기타 라틴아메리카
  • 중동
  • 이란
  • 이스라엘
  • 사우디아라비아
  • 아랍에미리트
  • 기타 중동
  • 아프리카

제4장 경쟁

KSA 25.11.27

Global Hospital Acquired Infection Control Market to Reach US$35.1 Billion by 2030

The global market for Hospital Acquired Infection Control estimated at US$30.7 Billion in the year 2024, is expected to reach US$35.1 Billion by 2030, growing at a CAGR of 2.2% over the analysis period 2024-2030. Protective Barrier, one of the segments analyzed in the report, is expected to record a 2.0% CAGR and reach US$11.1 Billion by the end of the analysis period. Growth in the Sterilization Equipment segment is estimated at 2.5% CAGR over the analysis period.

The U.S. Market is Estimated at US$8.3 Billion While China is Forecast to Grow at 3.0% CAGR

The Hospital Acquired Infection Control market in the U.S. is estimated at US$8.3 Billion in the year 2024. China, the world's second largest economy, is forecast to reach a projected market size of US$6.5 Billion by the year 2030 trailing a CAGR of 3.0% over the analysis period 2024-2030. Among the other noteworthy geographic markets are Japan and Canada, each forecast to grow at a CAGR of 1.9% and 1.9% respectively over the analysis period. Within Europe, Germany is forecast to grow at approximately 1.9% CAGR.

Global Hospital Acquired Infection Control Market - Key Trends and Drivers Summarized

Is Hospital Acquired Infection Control the Key to Safer Healthcare Environments?

Hospital-acquired infections (HAIs) are a significant concern in healthcare settings, but why is infection control so crucial for patient safety? Hospital-acquired infections occur when patients develop new infections while receiving care in hospitals or other medical facilities. These infections include conditions such as pneumonia, surgical site infections, bloodstream infections, and urinary tract infections, often caused by bacteria, viruses, or fungi. Effective infection control measures are essential for reducing the spread of these infections and protecting vulnerable patients.

The importance of infection control lies in its ability to prevent the transmission of dangerous pathogens within healthcare environments. Without stringent protocols, HAIs can prolong hospital stays, increase healthcare costs, and, in severe cases, lead to life-threatening conditions or death. With the rise of antibiotic-resistant organisms, the need for effective infection prevention measures has become more urgent. Infection control practices help maintain cleaner environments, improve patient outcomes, and reduce the spread of drug-resistant pathogens, making them a vital component of modern healthcare systems.

How Has Technology Advanced Hospital-Acquired Infection Control?

Technological advancements have significantly enhanced the tools and methods used for hospital-acquired infection control, making infection prevention more effective and efficient. One of the most impactful developments is the use of ultraviolet (UV) disinfection systems. UV-C light is used to sterilize surfaces and air in healthcare settings, killing pathogens that may otherwise remain after traditional cleaning. These systems have been widely adopted in operating rooms, intensive care units (ICUs), and patient rooms, providing an additional layer of protection against HAIs.

Automated hand hygiene monitoring systems are another innovation that has improved infection control efforts. These systems track and monitor hand hygiene compliance among healthcare workers, helping to ensure that proper sanitation protocols are followed. Hand hygiene is one of the most effective methods of preventing the spread of infections, and automated monitoring provides real-time data, allowing for timely interventions if compliance rates drop.

Advanced diagnostics and real-time surveillance tools have also transformed how hospitals manage infection control. Rapid diagnostic tests for pathogens allow for quicker identification of infections, enabling faster treatment and isolation of affected patients. Digital platforms and AI-driven analytics are used to track infection patterns within hospitals, providing insights into potential outbreaks before they occur. These tools help infection control teams identify high-risk areas and develop targeted interventions to stop the spread of infections.

Sterilization technologies have also evolved, improving the safety of medical equipment and tools. Low-temperature sterilization methods, such as vaporized hydrogen peroxide and plasma sterilizers, allow for the effective disinfection of heat-sensitive equipment, ensuring that surgical instruments and medical devices are free from harmful pathogens. These technologies are especially important for devices used in invasive procedures, where the risk of infection is higher.

The development of antimicrobial surfaces has added another layer of protection in infection control. Surfaces coated with materials like copper or silver have been shown to reduce the growth and spread of bacteria and other pathogens in healthcare environments. These antimicrobial surfaces are increasingly being used on high-touch areas like bed rails, door handles, and medical equipment, reducing the risk of HAIs through surface contact.

Why Is Hospital-Acquired Infection Control Critical for Patient Safety and Healthcare Efficiency?

Hospital-acquired infection control is critical for ensuring patient safety, reducing healthcare costs, and maintaining overall healthcare system efficiency. HAIs can severely impact patient health, particularly among those with weakened immune systems, chronic illnesses, or those recovering from surgery. Effective infection control measures prevent the transmission of pathogens, safeguarding vulnerable patients from potentially life-threatening infections that can complicate their treatment and recovery.

In addition to safeguarding patient health, infection control measures help prevent the spread of drug-resistant bacteria, such as methicillin-resistant Staphylococcus aureus (MRSA) and carbapenem-resistant Enterobacteriaceae (CRE). These superbugs are difficult to treat and can lead to severe complications, prolonged hospital stays, and even death. Infection control measures, such as proper hand hygiene, the use of personal protective equipment (PPE), and strict cleaning protocols, help limit the spread of these dangerous pathogens within healthcare facilities.

Infection control also improves healthcare efficiency by reducing the incidence of HAIs, which are costly and resource-intensive to manage. Patients who contract HAIs often require additional medical care, including extended hospital stays, more frequent doctor visits, and expensive medications. This increases the burden on healthcare facilities, leading to higher costs for both the hospital and the patient. By reducing infection rates, hospitals can optimize resource allocation, reduce patient readmission rates, and improve overall healthcare outcomes.

Another vital aspect of infection control is protecting healthcare workers from exposure to infectious agents. Healthcare workers are frequently exposed to blood, bodily fluids, and contaminated surfaces, putting them at risk for contracting infections. Proper infection control protocols, including PPE, surface disinfection, and vaccination programs, protect healthcare workers, ensuring they can continue to provide care without putting themselves or others at risk.

What Factors Are Driving the Growth of the Hospital-Acquired Infection Control Market?

The hospital-acquired infection control market is experiencing significant growth due to several key factors, including the rising incidence of HAIs, growing awareness of infection control measures, and advancements in healthcare technology. One of the primary drivers is the increasing prevalence of HAIs across the globe. As healthcare facilities treat more patients with complex medical needs, the risk of infections spreading in hospital settings has risen. This has prompted hospitals to invest in more effective infection control measures, from UV disinfection systems to advanced surveillance tools.

The rising awareness of the importance of infection prevention, particularly in light of global health challenges like the COVID-19 pandemic, has also driven the adoption of infection control technologies. Governments, healthcare institutions, and regulatory bodies are placing greater emphasis on improving infection control standards, with many countries implementing stricter regulations to reduce the incidence of HAIs. Public awareness of hospital safety has increased as well, leading to more demand for hospitals to demonstrate their commitment to infection prevention.

Technological advancements in disinfection and sterilization processes are also contributing to market growth. New disinfection technologies, such as UV-C and hydrogen peroxide vapor systems, have become more accessible and are being rapidly adopted in healthcare facilities worldwide. These technologies offer faster, more thorough disinfection than traditional cleaning methods, reducing the risk of pathogen transmission. Similarly, the rise of antimicrobial surfaces and advanced PPE is helping healthcare workers and patients stay safer from infections.

Another factor driving market growth is the increasing investment in healthcare infrastructure, particularly in emerging markets. As developing countries expand their healthcare systems, there is a growing need for infection control products and services to meet international healthcare standards. Many healthcare facilities in these regions are upgrading their equipment and protocols to improve patient safety and prevent the spread of HAIs.

Finally, the increasing focus on patient safety and quality care is influencing the adoption of more sophisticated infection control measures. Hospitals are under growing pressure to meet accreditation standards and demonstrate low infection rates to attract patients and maintain their reputations. Infection control systems, including real-time monitoring, advanced diagnostics, and automated disinfection, are becoming essential tools in achieving these goals.

With growing demand for infection prevention technologies, advancing healthcare infrastructure, and increasing awareness of the dangers posed by HAIs, the hospital-acquired infection control market is expected to expand rapidly. As healthcare facilities prioritize patient safety and efficiency, infection control measures will remain central to preventing HAIs and ensuring healthier outcomes for patients and healthcare workers alike.

SCOPE OF STUDY:

The report analyzes the Hospital Acquired Infection Control market in terms of units by the following Segments, and Geographic Regions/Countries:

Segments:

Product (Protective Barrier, Sterilization Equipment, Disinfectants, Other Products); End-Use (Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers, Other End-Uses)

Geographic Regions/Countries:

World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.

Select Competitors (Total 46 Featured) -

  • Advanced Sterilization Products
  • Alere, Inc.
  • Bayer AG
  • Belimed AG
  • Cepheid, Inc.
  • F. Hoffmann-La Roche AG
  • Getinge AB (Getinge Group)
  • MediVators, Inc.
  • Merck & Co., Inc.
  • Olympus Corporation
  • Pfizer, Inc.
  • Steelco SpA
  • Steris PLC

AI INTEGRATIONS

We're transforming market and competitive intelligence with validated expert content and AI tools.

Instead of following the general norm of querying LLMs and Industry-specific SLMs, we built repositories of content curated from domain experts worldwide including video transcripts, blogs, search engines research, and massive amounts of enterprise, product/service, and market data.

TARIFF IMPACT FACTOR

Our new release incorporates impact of tariffs on geographical markets as we predict a shift in competitiveness of companies based on HQ country, manufacturing base, exports and imports (finished goods and OEM). This intricate and multifaceted market reality will impact competitors by increasing the Cost of Goods Sold (COGS), reducing profitability, reconfiguring supply chains, amongst other micro and macro market dynamics.

TABLE OF CONTENTS

I. METHODOLOGY

II. EXECUTIVE SUMMARY

  • 1. MARKET OVERVIEW
    • Trade Shocks, Uncertainty, and the Structural Rewiring of the Global Economy
    • How Trump's Tariffs Impact the Market? The Big Question on Everyone's Mind
    • Global Economic Update
    • Hospital Acquired Infection Control - Global Key Competitors Percentage Market Share in 2025 (E)
    • Competitive Market Presence - Strong/Active/Niche/Trivial for Players Worldwide in 2025 (E)
  • 2. FOCUS ON SELECT PLAYERS
  • 3. MARKET TRENDS & DRIVERS
    • Expansion of Healthcare Infrastructure Spurs Adoption of Advanced HAI Control Measures
    • Growth in Hospital Admissions and Surgical Procedures Expands Addressable Market for HAI Control
    • Role of HAI Control in Enhancing Patient Safety and Reducing Healthcare Costs Strengthens Business Case for Adoption
    • Increasing Focus on Antimicrobial Resistance and Superbugs Fuels Market Demand for HAI Control Solutions
    • Growth in Use of Ultraviolet (UV) and Hydrogen Peroxide-based Disinfection Expands Market Opportunities
    • Technological Integration for Automated and Robotic Disinfection Systems Expands Market Potential
    • Growth in Demand for Single-use Medical Devices and Disposable Products Fuels Market Adoption
    • Increasing Focus on Hand Hygiene and Personal Protective Equipment (PPE) Expands Addressable Market
    • Growth in Use of Antimicrobial Coatings and Barrier Materials in Healthcare Settings Strengthens Market Opportunities
  • 4. GLOBAL MARKET PERSPECTIVE
    • TABLE 1: World Hospital Acquired Infection Control Market Analysis of Annual Sales in US$ Million for Years 2015 through 2030
    • TABLE 2: World Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 3: World Historic Review for Hospital Acquired Infection Control by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 4: World 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets for Years 2015, 2025 & 2030
    • TABLE 5: World Recent Past, Current & Future Analysis for Protective Barrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 6: World Historic Review for Protective Barrier by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 7: World 15-Year Perspective for Protective Barrier by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 8: World Recent Past, Current & Future Analysis for Sterilization Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 9: World Historic Review for Sterilization Equipment by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 10: World 15-Year Perspective for Sterilization Equipment by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 11: World Recent Past, Current & Future Analysis for Disinfectants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 12: World Historic Review for Disinfectants by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 13: World 15-Year Perspective for Disinfectants by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 14: World Recent Past, Current & Future Analysis for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 15: World Historic Review for Other Products by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 16: World 15-Year Perspective for Other Products by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 17: World Recent Past, Current & Future Analysis for Hospitals & ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 18: World Historic Review for Hospitals & ICUs by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 19: World 15-Year Perspective for Hospitals & ICUs by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 20: World Recent Past, Current & Future Analysis for Ambulatory Surgery & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 21: World Historic Review for Ambulatory Surgery & Diagnostic Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 22: World 15-Year Perspective for Ambulatory Surgery & Diagnostic Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 23: World Recent Past, Current & Future Analysis for Nursing Homes & Maternity Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 24: World Historic Review for Nursing Homes & Maternity Centers by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 25: World 15-Year Perspective for Nursing Homes & Maternity Centers by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030
    • TABLE 26: World Recent Past, Current & Future Analysis for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 27: World Historic Review for Other End-Uses by Geographic Region - USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 28: World 15-Year Perspective for Other End-Uses by Geographic Region - Percentage Breakdown of Value Sales for USA, Canada, Japan, China, Europe, Asia-Pacific, Latin America, Middle East and Africa for Years 2015, 2025 & 2030

III. MARKET ANALYSIS

  • UNITED STATES
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United States for 2025 (E)
    • TABLE 29: USA Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 30: USA Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 31: USA 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 32: USA Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 33: USA Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 34: USA 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CANADA
    • TABLE 35: Canada Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 36: Canada Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 37: Canada 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 38: Canada Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 39: Canada Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 40: Canada 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • JAPAN
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Japan for 2025 (E)
    • TABLE 41: Japan Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 42: Japan Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 43: Japan 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 44: Japan Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 45: Japan Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 46: Japan 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • CHINA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in China for 2025 (E)
    • TABLE 47: China Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 48: China Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 49: China 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 50: China Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 51: China Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 52: China 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • EUROPE
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Europe for 2025 (E)
    • TABLE 53: Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 54: Europe Historic Review for Hospital Acquired Infection Control by Geographic Region - France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 55: Europe 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for France, Germany, Italy, UK, Spain, Russia and Rest of Europe Markets for Years 2015, 2025 & 2030
    • TABLE 56: Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 57: Europe Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 58: Europe 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 59: Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 60: Europe Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 61: Europe 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • FRANCE
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in France for 2025 (E)
    • TABLE 62: France Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 63: France Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 64: France 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 65: France Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 66: France Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 67: France 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • GERMANY
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Germany for 2025 (E)
    • TABLE 68: Germany Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 69: Germany Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 70: Germany 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 71: Germany Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 72: Germany Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 73: Germany 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ITALY
    • TABLE 74: Italy Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 75: Italy Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 76: Italy 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 77: Italy Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 78: Italy Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 79: Italy 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED KINGDOM
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in the United Kingdom for 2025 (E)
    • TABLE 80: UK Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 81: UK Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 82: UK 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 83: UK Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 84: UK Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 85: UK 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SPAIN
    • TABLE 86: Spain Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 87: Spain Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 88: Spain 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 89: Spain Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 90: Spain Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 91: Spain 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • RUSSIA
    • TABLE 92: Russia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 93: Russia Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 94: Russia 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 95: Russia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 96: Russia Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 97: Russia 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF EUROPE
    • TABLE 98: Rest of Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 99: Rest of Europe Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 100: Rest of Europe 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 101: Rest of Europe Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 102: Rest of Europe Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 103: Rest of Europe 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ASIA-PACIFIC
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Asia-Pacific for 2025 (E)
    • TABLE 104: Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 105: Asia-Pacific Historic Review for Hospital Acquired Infection Control by Geographic Region - Australia, India, South Korea and Rest of Asia-Pacific Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 106: Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for Australia, India, South Korea and Rest of Asia-Pacific Markets for Years 2015, 2025 & 2030
    • TABLE 107: Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 108: Asia-Pacific Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 109: Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 110: Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 111: Asia-Pacific Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 112: Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AUSTRALIA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Australia for 2025 (E)
    • TABLE 113: Australia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 114: Australia Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 115: Australia 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 116: Australia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 117: Australia Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 118: Australia 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • INDIA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in India for 2025 (E)
    • TABLE 119: India Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 120: India Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 121: India 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 122: India Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 123: India Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 124: India 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SOUTH KOREA
    • TABLE 125: South Korea Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 126: South Korea Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 127: South Korea 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 128: South Korea Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 129: South Korea Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 130: South Korea 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF ASIA-PACIFIC
    • TABLE 131: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 132: Rest of Asia-Pacific Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 133: Rest of Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 134: Rest of Asia-Pacific Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 135: Rest of Asia-Pacific Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 136: Rest of Asia-Pacific 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • LATIN AMERICA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Latin America for 2025 (E)
    • TABLE 137: Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 138: Latin America Historic Review for Hospital Acquired Infection Control by Geographic Region - Argentina, Brazil, Mexico and Rest of Latin America Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 139: Latin America 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for Argentina, Brazil, Mexico and Rest of Latin America Markets for Years 2015, 2025 & 2030
    • TABLE 140: Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 141: Latin America Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 142: Latin America 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 143: Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 144: Latin America Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 145: Latin America 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ARGENTINA
    • TABLE 146: Argentina Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 147: Argentina Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 148: Argentina 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 149: Argentina Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 150: Argentina Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 151: Argentina 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • BRAZIL
    • TABLE 152: Brazil Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 153: Brazil Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 154: Brazil 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 155: Brazil Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 156: Brazil Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 157: Brazil 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MEXICO
    • TABLE 158: Mexico Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 159: Mexico Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 160: Mexico 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 161: Mexico Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 162: Mexico Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 163: Mexico 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF LATIN AMERICA
    • TABLE 164: Rest of Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 165: Rest of Latin America Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 166: Rest of Latin America 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 167: Rest of Latin America Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 168: Rest of Latin America Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 169: Rest of Latin America 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • MIDDLE EAST
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Middle East for 2025 (E)
    • TABLE 170: Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2024 through 2030 and % CAGR
    • TABLE 171: Middle East Historic Review for Hospital Acquired Infection Control by Geographic Region - Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 172: Middle East 15-Year Perspective for Hospital Acquired Infection Control by Geographic Region - Percentage Breakdown of Value Sales for Iran, Israel, Saudi Arabia, UAE and Rest of Middle East Markets for Years 2015, 2025 & 2030
    • TABLE 173: Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 174: Middle East Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 175: Middle East 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 176: Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 177: Middle East Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 178: Middle East 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • IRAN
    • TABLE 179: Iran Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 180: Iran Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 181: Iran 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 182: Iran Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 183: Iran Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 184: Iran 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • ISRAEL
    • TABLE 185: Israel Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 186: Israel Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 187: Israel 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 188: Israel Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 189: Israel Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 190: Israel 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • SAUDI ARABIA
    • TABLE 191: Saudi Arabia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 192: Saudi Arabia Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 193: Saudi Arabia 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 194: Saudi Arabia Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 195: Saudi Arabia Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 196: Saudi Arabia 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • UNITED ARAB EMIRATES
    • TABLE 197: UAE Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 198: UAE Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 199: UAE 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 200: UAE Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 201: UAE Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 202: UAE 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • REST OF MIDDLE EAST
    • TABLE 203: Rest of Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 204: Rest of Middle East Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 205: Rest of Middle East 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 206: Rest of Middle East Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 207: Rest of Middle East Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 208: Rest of Middle East 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030
  • AFRICA
    • Hospital Acquired Infection Control Market Presence - Strong/Active/Niche/Trivial - Key Competitors in Africa for 2025 (E)
    • TABLE 209: Africa Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 210: Africa Historic Review for Hospital Acquired Infection Control by Product - Protective Barrier, Sterilization Equipment, Disinfectants and Other Products Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 211: Africa 15-Year Perspective for Hospital Acquired Infection Control by Product - Percentage Breakdown of Value Sales for Protective Barrier, Sterilization Equipment, Disinfectants and Other Products for the Years 2015, 2025 & 2030
    • TABLE 212: Africa Recent Past, Current & Future Analysis for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses - Independent Analysis of Annual Sales in US$ Million for the Years 2024 through 2030 and % CAGR
    • TABLE 213: Africa Historic Review for Hospital Acquired Infection Control by End-Use - Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses Markets - Independent Analysis of Annual Sales in US$ Million for Years 2015 through 2023 and % CAGR
    • TABLE 214: Africa 15-Year Perspective for Hospital Acquired Infection Control by End-Use - Percentage Breakdown of Value Sales for Hospitals & ICUs, Ambulatory Surgery & Diagnostic Centers, Nursing Homes & Maternity Centers and Other End-Uses for the Years 2015, 2025 & 2030

IV. COMPETITION

샘플 요청 목록
0 건의 상품을 선택 중
목록 보기
전체삭제